AKT Phosphorylation of FOXK2 at Ser398 Impacts Breast Cancer Cell Growth and Viability

L T Carneiro, J M R C Nunes, G De Gregoriis, B S Mendonça, W M Araújo, R C Maia, E W F Lam, R S Carvalho, M A Carvalho, A D Sharrocks, G Nestal de Moraes · 2026

Read AKT Phosphorylation of FOXK2 at Ser398 Impacts Breast Cancer Cell Growth and Viability by L T Carneiro, J M R C Nunes, G De Gregoriis, B S Mendonça, W M Araújo, R C Maia, E W F Lam, R S Carvalho, M A Carvalho, A D Sharrocks, G Nestal de Moraes (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13660766.txt.

Description

L T Carneiro and co-authors study a gene switch in breast cancer cells in a 2026 paper. The switch, called FOXK2, can affect how cells respond to cancer drugs. Tumors with poor outlook often hold a lot of this protein, yet it seems to do little there. The team asked whether a growth signal protein marks the switch and changes what it does.

Tests showed high switch levels went with strong growth signals and drug resistance. One marked spot on the switch was found and confirmed with lab checks. A changed form of the switch that could not take the mark slowed cell growth. It also cut the cells' power to form new colonies, even with drugs present.

Catalog record

CREATORL T Carneiro, J M R C Nunes, G De Gregoriis, B S Mendonça, W M Araújo, R C Maia, E W F Lam, R S Carvalho, M A Carvalho, A D Sharrocks, G Nestal de Moraes
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE66 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13660766

Browse the full library · About the Tower of Babel